Navigation Links
Pharmaceutical Consortium Selects BioFortis Software to Manage Collaborative Clinical Data and Biobanking Activities
Date:3/14/2012

COLUMBIA, Md., March 14, 2012 /PRNewswire/ -- The PML Consortium, an association of pharmaceutical and biotechnology companies, has recently selected the Labmatrix and Qiagram software environments from BioFortis to share and manage data relating to biospecimens in a collaborative effort to study a serious adverse event.

Progressive multifocal leukoencephalopathy (PML) is an often-fatal disease caused by the JC virus in immunocompromised patients. PML has been identified as a known side effect to certain immunosuppressive drugs. Several pharmaceutical and biotechnology companies have established the PML Consortium in order to pool study resources together, so they can derive insights that otherwise might not be gained from separate, individual studies. Current members of the PML Consortium include Biogen Idec, Bristol-Myers Squibb, Elan, Pfizer, and Roche.

Through the web-accessible Labmatrix and Qiagram collaborative software environments, global PML Consortium members can 1). centrally manage de-identified or anonymized patient clinical profiles and biospecimen information in the virtual sample bank, 2). explore available biospecimens in the virtual sample bank and related data using complex, ad hoc criteria, 3). request, approve, and track transfers of biospecimens in the virtual sample bank, and  4). log user interactions and virtual sample bank inventory history for usage transparency, information security, and accountability.

"This application will enable us to store clinical data and sample data collected by the Consortium, and enable research to be carried out in an innovative collaborative effort and thorough scientific approach into PML and its causes," states Sophie Banzet, M.D., Chair of the PML Consortium Board of Directors.

"With the complementary capabilities of a transactional database for managing daily scientific operations, and a graphical data exploration engine for posing complex questions," states BioFortis CEO Jian Wang, Ph.D., "our software environment is an informatics one-stop-shop for the PML Consortium researchers and collaborators."

About BioFortis, Inc.

BioFortis, Inc. provides enterprise software solutions within several key application areas including translational research, biobanking, biomarker discovery and clinical research. With the ability to centralize life sciences data sets in a tightly-linked, highly-annotated, and user-friendly manner, our solutions help customers to standardize on best practices in research data management within the biopharmaceutical industry, academia and government research institutions. BioFortis' website address is www.BioFortis.com

Labmatrix and Qiagram are registered marks of BioFortis, Inc.


'/>"/>
SOURCE BioFortis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2011 Financial Results on March 12, 2012
2. Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
3. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
4. Swedish Bactiguard to Enter Into an Exclusive Distribution Agreement With Cadila Pharmaceuticals
5. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2011 Financial Results on Wednesday, March 7, 2012
6. BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals
7. Questcor Pharmaceuticals to Present at the Leerink Swann Global Healthcare Conference on February 16, 2012
8. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
9. Galien Foundation Announces 2012 Awards Program For Best Biopharmaceutical Products and Best Medical Technology
10. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
11. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2017)... Philadelphia, PA (PRWEB) , ... May 19, 2017 ... ... for its QED Proof-of-Concept Program. Academic researchers with technologies ripe for commercialization, ... Pennsylvania, New Jersey and Delaware, are encouraged to submit proposals. QED, now in ...
(Date:5/18/2017)... ... May 17, 2017 , ... ... its scientific power by providing investigators access to a high-profile scientific advisory ... the scientific advisory board. “We are committed to offering superior services and ...
(Date:5/18/2017)... ... 17, 2017 , ... Many complicated neurological disorders appear to ... disease, while men are at greater risk for Parkinson’s disease. Understanding some of ... aim of a research program at Worcester Polytechnic Institute (WPI) funded by a ...
(Date:5/16/2017)... (PRWEB) , ... May 16, 2017 , ... ... technology and cancer diagnostics, has released its ClearID Lung Cancer blood test. Leveraging ... lung cancer, this new test is designed to quickly and accurately identify tumor-related ...
Breaking Biology Technology:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/28/2017)... PUNE, India , March 28, 2017 ... (Analog, IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), ... Maintenance), Vertical, and Region - Global Forecast to 2022", ... 30.37 Billion in 2016 and is projected to reach ... 15.4% between 2017 and 2022. The base year considered ...
(Date:3/23/2017)... -- Research and Markets has announced the addition of ... Industry Forecast to 2025" report to their offering. ... The Global Vehicle Anti-Theft ... 8.8% over the next decade to reach approximately $14.21 billion by ... and forecasts for all the given segments on global as well ...
Breaking Biology News(10 mins):